Description Enrofloxacin(BAY-Vp2674; PD160788) is a fluoroquinolone antibiotic. Target: Antibacterial Enrofloxacin is a fluoroquinolone antibiotic sold by the Bayer Corporation under the trade name Baytril. Enrofloxacin is currently approved by the FDA for the treatment of individual pets and domestic animals in the United States. Enrofloxacin is a bactericidal agent. The bactericidal activity of enrofloxacin is concentration-dependent, with susceptible bacteria cell death occurring within 20-30 minutes of exposure. Enrofloxacin has demonstrated a significant post-antibiotic effect for both Gram-negative and Gram-positive bacteria and is active in both stationary and growth phases of bacterial replication. Enrofloxacin has antibacterial activity against a broad spectrum of Gram-negative and Gram-positive bacteria. Its mechanism of action is not thoroughly understood, but it is believed to act by inhibiting bacterial DNA gyrase (a type-II topoisomerase), thereby preventing DNA supercoiling and DNA synthesis
Preparing Stock Solutions
Concentration Volume Mass 1 mg 5 mg 10 mg


1 mM 2.7825 mL 13.9125 mL 27.8249 mL
5 mM 0.5565 mL 2.7825 mL 5.5650 mL
10 mM 0.2782 mL 1.3912 mL 2.7825 mL

Please refer to the solubility information to select the appropriate solvent.

Molecular Weight 359.39
Formula C₁₉H₂₂FN₃O₃
CAS No. 93106-60-6
Powder -20°C 3 years
  4°C 2 years
In solvent -80°C 6 months
  -20°C 1 month


Shipping Room temperature in continental US; may vary elsewhere
Solvent & Solubility DMSO: 1 mg/mL; H2O: < 1 mg/mL

* “<1 mg/mL” means slightly soluble or insoluble. “≥” means soluble, but saturation unknown.

Enrofloxacin-COA HUISUN


电子邮件地址不会被公开。 必填项已用*标注